Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 169, Issue 6, Pages 1188-1197Publisher
WILEY-BLACKWELL
DOI: 10.1111/bjd.12578
Keywords
-
Categories
Funding
- National Institutes of Health SPORE Program [5P50CA121973-05]
- National Center for Research Resources [UL1 RR024153]
- Howard Hughes Medical Fellows Program
Ask authors/readers for more resources
Gene expression studies of cutaneous T-cell lymphoma (CTCL) span a decade, yet the pathogenesis is poorly understood and diagnosis remains a challenge. This review examines the varied approaches to gene expression analysis of CTCL, with emphasis on cell populations, control selection and expression data collection. Despite discordant results, several dysregulated genes have been identified across multiple studies, including PLS3, KIR3DL2, TWIST1 and STAT4. Here, we provide an overview of the most consistently expressed genes across different studies andbring them togetherthroughcommon pathways biologically relevant to CTCL. Four pathways - evasion of activation-induced cell death, T helper 2 lymphocyte differentiation, transforming growth factor- receptor expression, and tumour necrosis factor receptor ligands - appear to encompass the most frequently affected genes, hypothetically providing insight into the disease pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available